Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD
Observational · No treatment assigned · 2 sites · Asian Institute of Gastroenterology, India
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Ulcerative Colitis (UC) and Crohns Disease. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 to 80
- Any sex
Some of the main requirements, copied from the record:
- All consecutive patients undergoing endoscopy procedures with consent for procedures, during the study period will be included
Only the trial team can confirm whether you qualify.
What's involved
- About 200 participants are expected to take part.
- Start date: 2026-03-01.
- Main results expected around 2026-12 (estimate from the record).
- 2 study sites listed (2 marked recruiting) in India.
Main thing being measured
- The electricity consumed, water consumed, waste generated, and Greenhouse Gas (GHG) emissions will be analyzed (12 months)
In the researchers’ words
Healthcare contributes approximately 4.4% of global GHG emissions, with diagnostic imaging and endoscopic services being substantial contributors. Colonoscopy and cross-sectional imaging modalities, though indispensable, are associated with high carbon emissions due to electricity use, waste, sterilisation, and transportation.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Ulcerative Colitis (UC); Crohns Disease |
| Lead sponsor | Asian Institute of Gastroenterology, India |
| Enrollment | 200 (estimated) |
| Start date | 2026-03-01 |
| Primary completion (est.) | 2026-12 |
| First posted | 2026-02-25 |
| Last updated | 2026-05-12 |
| Official title | Prospective Evaluation of the Carbon Footprint and Clinical Utility of Intestinal Bowel Ultrasound Compared to Colonoscopy and Enterography in Ulcerative Colitis and Crohn's Disease |
| ClinicalTrials.gov ID | NCT07431983 |
Interventions
- None listed
Full eligibility criteria (from the record)
All consecutive patients undergoing endoscopy procedures with consent for procedures, during the study period will be included
Locations (2)
| Site | City | Country | Site status |
|---|---|---|---|
| AIG Hospitals | Hyderabad, Telangana | India | Recruiting |
| AIG Hospitals | Hyderabad, Telangana | India | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.